Technological Innovation in Health Care and the Long-Term Fiscal Outlook

医疗保健技术创新和长期财政前景

基本信息

  • 批准号:
    8750769
  • 负责人:
  • 金额:
    $ 39.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-15 至 2016-06-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Over the past 50 years, longevity has risen at a steady pace. Functional status of the elderly has also witnessed important improvements, although gains have leveled off recently. These improvements do not come without costs. The United States has devoted an increasing share of its income to health care over that same period. In part because of the projected increase of health costs, the long-term fiscal outlook of the U.S. presents important challenges. Fiscal forecasts from the Congressional Budget Office and the Centers for Medicare & Medicaid Services (CMS) are dire, with Medicare spending alone projected to more than double as a share of national income, from 3.7% today to 7.3% in 2050. However, these forecasts take the driver of health care costs-technology-as exogenous, or fixed. This is unrealistic. We know innovators maximize the expected value of a future profit stream, and they will take into account the demand for their innovations in the future. The proposed research will marry two distinct but complementary approaches from the health policy and macroeconomic fields. First, we will incorporate technological change, and its determinants, into existing models projecting the long- term fiscal outlook of the U.S. Our engine will be an economic-demographic microsimulation that covers the population aged 25 and older, the Future Americans Model (FAM). This approach will examine granular technological change to understand consequences for spending and population health. Second, we will build a macroeconomic growth model to understand endogenous innovation and health care spending in overlapping generations (OLG) that incorporates the projections of our economic-demographic simulation. Such OLG models have proven very useful for understanding long-run economic outcomes and their effects on government debt. Results from the OLG model will complement the results of the FAM by revealing the fiscal paths consistent with a balanced government budget when taking behavioral and macroeconomic changes into account. There are four principal outcomes of this project. First, we will quantify the fiscal consequences of various innovation scenarios. Second, the research will identify scenarios under which new innovations will impact health by effectively treating one disease while simultaneously impacting innovation for other diseases. Third, the project will identify scenarios under which health spending would rise or fall in future years as a result of technological change and how health spending can be financed with minimum welfare consequences using the FAM-calibrated OLG model. Fourth, by combining behavioral models with simulation models such as the Future Americans Model, this project will advance the state of knowledge on the possibilities of combining different approaches to make long-term fiscal forecasts.
描述(由申请人提供):在过去的50年里,寿命稳步增长。老年人的功能状况也有了重大改善,尽管最近进展趋于平稳。这些改进并非没有代价。在同一时期,美国将越来越多的收入用于保健。部分由于预计医疗费用将增加,美国的长期财政前景面临重大挑战。来自国会预算办公室和医疗保险和医疗补助服务中心(CMS)的财政预测是可怕的,仅医疗保险支出就预计将占国民收入的两倍以上,从今天的3.7%增加到2050年的7.3%。然而,这些预测将医疗保健成本的驱动因素-技术-视为外生的或固定的。这是不现实的。我们知道,创新者会最大化未来利润流的预期价值,他们会考虑未来对其创新的需求。拟议的研究将结合卫生政策和宏观经济领域两种不同但互补的方法。首先,我们将把技术变革及其决定因素纳入预测美国长期财政前景的现有模型中。我们的引擎将是一个涵盖25岁及以上人口的经济人口微观模拟,即未来美国人模型(FAM)。这种方法将检查颗粒技术变化,以了解支出和人口健康的后果。其次,我们将建立一个宏观经济增长模型,以了解内生创新和医疗保健支出在重叠的世代(OLG),结合我们的经济人口模拟的预测。事实证明,这种OLG模型对于理解长期经济结果及其对政府债务的影响非常有用。OLG模型的结果将补充FAM的结果,揭示在考虑行为和宏观经济变化时与平衡政府预算相一致的财政路径。该项目有四个主要成果。首先,我们将量化各种创新情景的财政后果。其次,研究将确定新的创新将通过有效治疗一种疾病同时影响其他疾病的创新来影响健康的情景。第三,该项目将确定未来几年由于技术变革而导致卫生支出上升或下降的情景,以及如何使用FAM校准的OLG模型在最小福利后果的情况下为卫生支出提供资金。第四,通过将行为模型与“未来美国人模型”等模拟模型相结合,提高对综合运用各种方法进行长期财政预测的可能性的认识。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DANA P GOLDMAN其他文献

DANA P GOLDMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DANA P GOLDMAN', 18)}}的其他基金

Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
阿尔茨海默病及相关痴呆症社会人口学和经济研究推进中心 (CeASES-ADRD)
  • 批准号:
    10216946
  • 财政年份:
    2020
  • 资助金额:
    $ 39.97万
  • 项目类别:
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
阿尔茨海默病及相关痴呆症社会人口学和经济研究推进中心 (CeASES-ADRD)
  • 批准号:
    10417203
  • 财政年份:
    2020
  • 资助金额:
    $ 39.97万
  • 项目类别:
Center for Advancing Sociodemographic and Economic Study of Alzheimer’s Disease and Related Dementias (CeASES-ADRD)
阿尔茨海默病及相关痴呆症社会人口学和经济研究推进中心 (CeASES-ADRD)
  • 批准号:
    10657377
  • 财政年份:
    2020
  • 资助金额:
    $ 39.97万
  • 项目类别:
Precision Medicine: Moving Theory into Practice
精准医学:将理论付诸实践
  • 批准号:
    9752826
  • 财政年份:
    2019
  • 资助金额:
    $ 39.97万
  • 项目类别:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
确保获得新型阿尔茨海默病和痴呆症治疗方法:评估创新的支付方式
  • 批准号:
    9977782
  • 财政年份:
    2018
  • 资助金额:
    $ 39.97万
  • 项目类别:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
确保获得新型阿尔茨海默病和痴呆症治疗方法:评估创新的支付方式
  • 批准号:
    10176332
  • 财政年份:
    2018
  • 资助金额:
    $ 39.97万
  • 项目类别:
Ensuring Access to Novel Alzheimer’s and Dementia Treatments: Evaluating Innovative Payment Approaches
确保获得新型阿尔茨海默病和痴呆症治疗方法:评估创新的支付方式
  • 批准号:
    9789172
  • 财政年份:
    2018
  • 资助金额:
    $ 39.97万
  • 项目类别:
The Long-Term Benefits of Interventions to Improve T2D Outcomes
改善 T2D 结局的干预措施的长期益处
  • 批准号:
    9176837
  • 财政年份:
    2016
  • 资助金额:
    $ 39.97万
  • 项目类别:
The Long-Term Benefits of Interventions to Improve T2D Outcomes
改善 T2D 结局的干预措施的长期益处
  • 批准号:
    9321379
  • 财政年份:
    2016
  • 资助金额:
    $ 39.97万
  • 项目类别:
USC Resource Center for Minority Aging Research (US-RCMAR)
南加州大学少数民族老龄化研究资源中心 (US-RCMAR)
  • 批准号:
    8987153
  • 财政年份:
    2015
  • 资助金额:
    $ 39.97万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
  • 批准号:
    23K07844
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
  • 批准号:
    22KJ2960
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
    Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
  • 批准号:
    23KK0156
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
    Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
  • 批准号:
    10677409
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
  • 批准号:
    497927
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
  • 批准号:
    10836835
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
  • 批准号:
    10679287
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
  • 批准号:
    478877
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
    Operating Grants
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
  • 批准号:
    23K06378
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
  • 批准号:
    23K10845
  • 财政年份:
    2023
  • 资助金额:
    $ 39.97万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了